Immunic Inc Share Price

NASDAQ: IMUX

Small Cap

$0.83

(+0.18%)

Live

as on September 18, 2025 at 11:37 pm IST

$₹

Immunic Inc Stock Performance

as on September 18, 2025 at 11:37 pm IST

Day's Low
Day's High
$0.82
Day's Price Range
$0.85
$0.83
1.20%
Downside
2.41%
Upside
52 Week's Low
52 Week's High
$0.56
52-Week Price Range
$2.11
$0.83
32.41%
Downside
154.22%
Upside

Immunic Inc share price movements today

Previous Close: $0.83
Open: $0.83
Volume: 486.1K
Day's Low - High: $0.82 - $0.85
52 Week Low - High: $0.56 - $2.11

Immunic Inc Historical Returns

1 Month Return: -15.21 %
3 Month Return: + 11.16 %
1 Year Return: -53.65 %
3 Year Return: -78.78 %
5 Year Return: -95.49 %

Immunic Inc Stock Fundamentals & Key Indicators

Check Immunic Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$81.9M

EPS (TTM)

-0.7083

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-105.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

14391600.00%

Immunic Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunic Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Immunic Inc	BUY	$81.9M	-95.49%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Immunic Inc Stock including INR - Dollar returns

The Immunic Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y
7Y
10Y

Immunic Inc investment value today

Current value as on today

₹51,322

Returns

₹48,678

(-48.68%)

Returns from Immunic Inc Stock

₹53,631 (-53.63%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Immunic Inc Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Immunic Inc. Average target price of $7.47

Immunic Inc Share Price Target

Get share price movements and forecasts by analysts on Immunic Inc.

What analysts predicted

88.89%UPSIDE

Target Price

$7.47

Current Price

$0.83

Analyzed by

11 Analysts

Target

$7.47

Immunic Inc target price $7.47, a slight upside of 88.89% compared to current price of $0.83. According to 11 analysts rating.

Immunic Inc Stock's Interest Amongst Investors

Search interest for Immunic Inc Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:71% versus previous 30 day period

Immunic Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-27	-25	-23	-23	-23	-22	-25	-25	-26	-27
EBITDA	-27	-24	-23	-23	-23	-22	-25	-25	-26	-26
Interest Expense	2	-	-	2	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-25	-23	-22	-21	-29	-21	-24	-25	-25	-26
Income Tax Expense	-2	0	0	3	0	-	-	0	-	-
Net Income	-23	-23	-22	-21	-29	-21	-24	-25	-25	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-22083.33%	0.00%	0.00%

Immunic Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-41	-52	-42	-37	-48	-91	-119	-99	-98
EBITDA	-39	-51	-15	-36	-48	-91	-120	-99	-100
Interest Expense	-	-	-	0	0	0	1	-	-
Depreciation	-	0	0	0	0	0	0	0	0
Income Before Tax	-40	-52	-41	-34	-44	-92	-120	-93	-100
Income Tax Expense	-1	0	0	0	0	0	33	-	-100
Net Income	-40	-52	-41	-34	-43	-92	-120	-93	-100
Net Profit Margin	-682816.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Immunic Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-23	-22	-21	-29	-21	-24	-25	-25	-26
Operating Cash Flow	-19	-17	-14	-23	-17	-20	-22	-21	-24
Investing Cash Flow	4	0	0	0	0	0	0	0	0
Financing Cash Flow	0	0	0	74	-	-	0	-	65
Change in Cash	-15	-17	-13	50	-17	-20	-23	-21	41

Immunic Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-40	-52	-41	-34	-44	-92	-120	-93	-100
Operating Cash Flow	-35	-40	-43	-28	-46	-83	-65	-70	-84
Investing Cash Flow	0	0	0	10	0	0	-9	9	0
Financing Cash Flow	12	37	0	34	144	42	95	1	74
Change in Cash	-23	-3	-43	16	98	-40	19	-60	-11

Global Institutional Holdings in Immunic Inc

Funds	Holdings
Bvf Inc	9.29%
Aberdeen Group PLC	8.6%
Soleus Capital Management, L.P.	7.61%
Avidity Partners Management LP	4.65%
Vanguard Group Inc	4.1%

See all

Insights on Immunic Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 122.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 190.3%
NEGATIVE IMPACT
Price Dip
In the last 1 month, IMUX stock has moved down by -15.2%

About Immunic Inc

immunic, inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, crohn's disease, and psoriasis. its lead development program is imu-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme dihydroorotate dehydrogenase, which is in phase 2 clinical development for treatment of ulcerative colitis and relapsing-remitting multiple sclerosis, as well as in phase 2 trial to treat crohn's disease. the company is also developing imu-935, an inverse agonist of rorgt; and imu-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. immu

Organisation	Immunic Inc
Headquarters	1200 Avenue of the Americas, New York, NY, United States, 10036
Industry	Pharmaceuticals: Major
CEO	Dr. Daniel Vitt Ph.D.
E-voting on shares	Click here to vote

Key Management of Immunic Inc

Name	Title
Dr. Duane D. Nash J.D., M.B.A., M.D.	Executive Chairman
Dr. Daniel Vitt Ph.D.	CEO & Director
Mr. Jason Tardio M.B.A.	COO & President
Mr. Inderpal Singh	General Counsel
Mr. Glenn Whaley CPA	Chief Financial Officer
Dr. Andreas Muehler M.D., Ph.D.	Chief Medical Officer
Dr. Hella Kohlhof	Chief Scientific Officer
Ms. Jessica Breu	Head of Investor Relations & Communications
Mr. Patrick Walsh	Chief Business Officer
Mr. Werner Gladdines	Chief Development Officer

FAQs

What is Immunic Inc share price today?

Immunic Inc share price today is $0.83 as on September 18, 2025 at 11:37 pm IST. Immunic Inc share today touched a day high of $0.85 and a low of $0.82.

What is the 52 week high and 52 week low for Immunic Inc share?

Immunic Inc share touched a 52 week high of $2.11 on September 19, 2024 and a 52 week low of $0.56 on May 29, 2025. Immunic Inc stock price today i.e. September 18, 2025 at 11:37 pm IST is trending at $0.83,which is 60.66% down from its 52 week high and 47.95% up from its 52 week low.

What is Immunic Inc's market capitalisation today?

Immunic Inc market capitalisation is $0.00T as on September 18, 2025 at 11:37 pm IST.

How to invest in Immunic Inc Stock (IMUX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Immunic Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunic Inc Shares that will get you 1.8072 shares as per Immunic Inc share price of $0.83 per share as on September 18, 2025 at 11:37 pm IST.

What is the minimum amount required to buy Immunic Inc Stock (IMUX) from India?

Indian investors can start investing in Immunic Inc (IMUX) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 11:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Immunic Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 11:39 pm IST). Based on Immunic Inc share’s latest price of $0.83 as on September 18, 2025 at 11:37 pm IST, you will get 12.0482 shares of Immunic Inc. Learn more about fractional shares .

What are the returns that Immunic Inc has given to Indian investors in the last 5 years?

Immunic Inc stock has given -95.49% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?